Cumberland Pharmaceuticals (CPIX) Retained Earnings (2016 - 2026)
Cumberland Pharmaceuticals' Retained Earnings history spans 16 years, with the latest figure at -$26.8 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 11.83% to -$26.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26.8 million, a 11.83% decrease, with the full-year FY2025 number at -$26.8 million, down 11.83% from a year prior.
- Retained Earnings hit -$26.8 million in Q4 2025 for Cumberland Pharmaceuticals, down from -$25.4 million in the prior quarter.
- Over the last five years, Retained Earnings for CPIX hit a ceiling of -$735625.0 in Q2 2021 and a floor of -$26.8 million in Q4 2025.
- Historically, Retained Earnings has averaged -$14.0 million across 5 years, with a median of -$11.2 million in 2022.
- The widest YoY moves for Retained Earnings: up 3.9% in 2021, down 1385.67% in 2021.
- Tracing CPIX's Retained Earnings over 5 years: stood at -$5.6 million in 2021, then tumbled by 98.79% to -$11.2 million in 2022, then plummeted by 56.02% to -$17.5 million in 2023, then plummeted by 37.05% to -$24.0 million in 2024, then dropped by 11.83% to -$26.8 million in 2025.
- Business Quant data shows Retained Earnings for CPIX at -$26.8 million in Q4 2025, -$25.4 million in Q3 2025, and -$23.5 million in Q2 2025.